Phase II study of low-dose Nab-paclitaxel for advanced breast cancer
Latest Information Update: 08 Feb 2019
At a glance
- Drugs Paclitaxel (Primary) ; Trastuzumab
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 04 Feb 2019 Status changed from recruiting to discontinued.
- 18 Oct 2013 New trial record